Dr. Hu Shanlian, MD. MSc. Professor of Health Economics, School of Public Health, Fudan University. At present, he has several social responsibilities, such as the senior consultant of Shanghai Health Development Research Center, Deputy guiding group leader of Comprehensive Health System Reform in Shanghai Municipal and Jiangsu, Zhejiang, Anhui, Fujian provinces, member of Advisory Committee of Public Policy in National Health and Family Planning Commission, member of China Eradication of Poliomyelitis Committee, Deputy Director of Health Technology Assessment Sub-Committee, Chinese Health Economics Association, senior consultant of Pharmacoeconomics Sub-Committee of China Association of Traditional Chinese Medicine and senior researcher of National Drug Policy & Pharmaceutical Industry Economic Research Center in China Pharmaceutical University.

He was the member of State Counsel Advisory Committee on Deepening Health Care System Reform (2001-2015), Director of Shanghai Health Development Research Center (2008-2016), Deputy Director of China Health Economic Institute (1993-2000), Coordinator of Training and Research Network in China Health Economics (1992-2005), Deputy Dean, School of Public Health, Shanghai Medical University (1985-1992) and Director of Training Center for Health Management (1985-2000), Director of Pharmacoeconomics Evaluation and Research Center in Fudan University. Member of Steering Committee, Alliance for Health Policy and Systems Research, the World Health Organization, Board Member of International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the Chairman of Asian ISPOR (2008-2010), as well as a temporary consultant for World Health Organization (WHO), World Bank (WB), United Nations International Children's Emergency Fund (UNICEF) and Australian Assistance for International Development (AUSAID). He received a Health Policy Research Award by Chinese Medical Association in 2014.